Peripheral T-cell Lymphoma Clinical Trials Database - Free Access to 40 Studies
Access comprehensive clinical trial information for Peripheral T-cell Lymphoma through Pure Global AI's free database. This collection includes 40 clinical trials across multiple phases including Phase 2, Phase 1, Phase 3. Currently, 11 trials are actively recruiting participants.
Research for Peripheral T-cell Lymphoma is being conducted in China, Japan, United States of America and 7+ other countries. Leading sponsors include Ruijin Hospital and Acrotech Biopharma Inc.. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy
Linperlisib Combined With Chidamide in Patients With PTCL
Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma
CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma
Efficacy and Safety of Cladribine Combined With BEAC Pretreatment Regimen in the Treatment of Peripheral T-cell Lymphoma: a Multicenter Clinical Study
A Study of TQ-B3525 in Subjects With Relapsed/Refractory Peripheral T-cell Lymphoma（PTCL）
A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression
Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma
Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy
Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma
A Study of PD-1/CTLA-4 Bispecific AK104 in Relapsed or Refractory Peripheral T-cell Lymphoma
A Multi-Center, Phase 2, Open-label, Parallel Cohort Study of Efficacy and Safety of Duvelisib in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Sintilimab (IBI308) in Combination With Chidamide and Azacitidine in Refractory or Relapsed PTCL
PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma
Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma
Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
A Study of Duvelisib in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)
Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell Lymphoma
Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients
Pure Global AI provides free access to 40 clinical trials studying Peripheral T-cell Lymphoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Ruijin Hospital, Acrotech Biopharma Inc., Mingzhi Zhang, among others.